Cannon Global Investment Management, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1844427
DAVIE, FL
Position in MDGL
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$805,425
+$386,649 QoQ
Shares Held
1,500
+87.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
#214
of 413 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Mar 31, 2026CallValue
$1,046,940
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Global Investment Management, LLC holds $3,747,880 across 6 Biotechnology names. MDGL ranks #1 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
1,500 | $805,425 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,500 | $752,575 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
4,000 | $749,120 | |
| 4 | ABVX |
Abivax S.A.
|
5,300 | $706,278 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
5,900 | $559,025 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
10,321 | $175,457 |
All Filings in MDGL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $805,425 | 1,500 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,046,940 | 2,000 | Call | Sole | 2026-04-21 | |
| 2026-03-31 | $418,776 | 800 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $407,638 | 700 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $366,928 | 800 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $242,112 | 800 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $496,845 | 1,500 | Shares | Sole | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||